diethylnitrosamine has been researched along with sphingosine kinase in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Crespo, I; de Urbina, JO; González-Fernández, B; González-Gallego, J; San-Miguel, B; Sánchez, DI; Tuñón, MJ | 1 |
| Funaki, M; Honda, M; Kaneko, S; Kitabayashi, J; Murai, K; Nagata, N; Okada, H; Ota, T; Oyama, T; Sakai, Y; Shimakami, T; Shirasaki, T; Takegoshi, K; Takuwa, Y; Yamashita, T | 1 |
2 other study(ies) available for diethylnitrosamine and sphingosine kinase
| Article | Year |
|---|---|
Melatonin prevents deregulation of the sphingosine kinase/sphingosine 1-phosphate signaling pathway in a mouse model of diethylnitrosamine-induced hepatocellular carcinoma.
Topics: Animals; Blotting, Western; Carcinogens; Carcinoma, Hepatocellular; Diethylnitrosamine; Disease Models, Animal; Immunohistochemistry; Liver Neoplasms; Lysophospholipids; Male; Melatonin; Mice; Mice, Inbred ICR; Phosphotransferases (Alcohol Group Acceptor); Real-Time Polymerase Chain Reaction; Signal Transduction; Sphingosine | 2017 |
Peretinoin, an acyclic retinoid, inhibits hepatocarcinogenesis by suppressing sphingosine kinase 1 expression in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Diethylnitrosamine; Gene Expression Regulation, Enzymologic; Hepatitis C; Humans; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Neoplasms, Experimental; Mice, Knockout; Mice, Transgenic; Phosphotransferases (Alcohol Group Acceptor); Retinoids; Sphingolipids | 2017 |